Legal expert Luzius Wildhaber, first president of ECHR, dies
Luzius Wildhaber, an international law expert and Professor Emeritus of the University of Basel, has died aged 83. He was the first full-time president of the European Court of Human Rights (ECHR).
This content was published on
1 minute
Keystone-SDA/ts
After studying in Basel, Paris, Heidelberg, London and Yale University in the US and a professorship in Fribourg, Wildhaber taught constitutional and international law in his hometown of Basel from 1977 to 1998.
Wildhaber was a part-time judge at the State Court of Liechtenstein from 1975 to 1988. In 1991 he became a judge at the ECHR in Strasbourg, France. He was its first full-time president from 1998 until his retirement in 2007.
In an obituaryExternal link, the ECHR said those who had worked with Wildhaber had met him with great respect and affection. “They will recall his humanity, his sense of humour, his culture and his endlessly enquiring mind. Today the court mourns its former president and is proud to have counted him as one of its number.”
In addition, Wildhaber was head of the expert commission on the total revision of the Swiss Federal Constitution and a member of numerous expert commissions and international arbitration tribunals.
Swiss invention: 90-year anniversary of first T-bar ski lift
This content was published on
On Monday it will be 90 years since the world’s first T-bar ski lift went into service in Davos. This Swiss invention was an instant success.
Iran summons Swiss ambassador over US and Italy arrests
This content was published on
Iran has summoned the Swiss ambassador, who represents US interests, to protest against the arrest in the US and Italy of two Iranians.
Swisscom receives greenlight for acquisition of Vodafone Italia
This content was published on
The takeover of Vodafone Italia by Swisscom is nearing completion. All relevant authorities have now approved the €8 billion (CHF7.45 billion) deal.
Novo Nordisk stock market plunge drags down Swiss device maker Ypsomed
This content was published on
The Danish pharmaceutical giant, Novo Nordisk, faced setbacks on Friday that weighed on the share price of Swiss injection device manufacturer Ypsomed.
Swiss press react to EU deal with mix of euphoria and scepticism
This content was published on
Swiss media reaction to the agreement between Switzerland and the EU varies widely. Some are celebrating, while others worry about what is to come.
Swiss Solidarity donations to tackle child abuse top CHF4 million
This content was published on
Swiss Solidarity, the humanitarian arm of the Swiss Broadcasting Corporation (SBC), has raised over CHF4 million ($4.3 million) to tackle child abuse.
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.
Read more
More
Breaking new ground for human rights
This content was published on
The 47-year-old Swiss professor of law at Zurich University was last week appointed as a judge at the European Court of Human Rights in Strasbourg. The possibility of passing verdicts which break new ground in human rights law is a key fascination in taking up the position, Keller tells swissinfo.ch on the occasion of her…
This content was published on
A law professor, Malinverni tells swissinfo about the importance of the Strasbourg court, which monitors compliance of the European Court of Human Rights Convention in the 46 member states of the Council of Europe. Malinverni has been the Swiss representative at the court since the beginning of the year. In 2006 there were nine judgements…
This content was published on
At a Council of Europe summit in Warsaw on Tuesday, Schmid also gave his support to moves to define relations between the Council and the recently expanded European Union. Schmid made his comments about the Council of Europe’s legal body on the final day of the historic two-day meeting, which was attended by 46 countries.…
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.